Skip to main content

Table 3 Results of Cox's multivariate regresssion analysis for BLI, HER status and known prognostic variables

From: Outcome and Human Epithelial Growth Factor Receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated using bromodeoxyuridine (BrdU) labelling

Variables (n = 48) p value
Grade 0.155
Size 0.008
Nodal status 0.283
ER status 0.197
BLI 0.052
HER1-3 status 0.003
HER4 status 0.985